COMMUNIQUÉS West-GlobeNewswire

SeaSpine Announces Fourth Quarter and Full-Year 2018 Results and Reaffirms 2019 Revenue Guidance

27/02/2019 - 22:05

CARLSBAD, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Imagin Medical Reports Fiscal 2019 First Quarter Results

27/02/2019 - 22:05

VANCOUVER, British Columbia and BOSTON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results [...]

GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results

27/02/2019 - 22:05

Pre-NDA Meeting Completed and Company Announces FDA Agreed to a Rolling Submission of New Drug Application for Voxelotor for the Potential Treatment of Sickle Cell Disease SOUTH SAN FRANCISCO, Calif., Feb. 27, 2019 ( [...]

Sarepta Therapeutics Announces Fourth Quarter 2018 and Full-Year 2018 Financial Results and Recent Corporate Developments

27/02/2019 - 22:05

RNA Franchise Advances -Reported EXONDYS 51® (eteplirsen) net sales of $84.4M for the quarter and full-year net sales of $301.0M, in line with guidance- -Filed NDA for golodirsen with priority review, PDUFA August 19 th [...]

Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

27/02/2019 - 22:01

-- NUZYRA™ (omadacycline) Launched in the United States for the Treatment of CABP and ABSSSI -- -- New England Journal of Medicine Publishes Results from Two Pivotal Phase 3 Studies of NUZYRA -- -- Company Executes [...]

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss 2018 Financial Results and Provide Corporate Update

27/02/2019 - 22:01

BURNABY, British Columbia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its 2018 financial and operating [...]

Collegium Reports Fourth-Quarter and Full-Year 2018 Financial Results

27/02/2019 - 22:01

Xtampza ® ER Prescriptions Grew 233% in 2018 Net Revenue Increased to $73.4 Million for Fourth Quarter 2018 and $280.4 Million for the Full Year Cash and Cash Equivalents were $146.6 million as of December 31, 2018, [...]

FDA Grants T2 Biosystems Breakthrough Device Designation for the T2Resistance™ Panel; Expected Availability through CE Mark in 2019

27/02/2019 - 22:01

New, expanded panel detects gram-negative and gram-positive resistance genes to help combat antimicrobial resistant bloodstream infections LEXINGTON, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- The FDA has granted T2 [...]

Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results

27/02/2019 - 22:01

Fourth-quarter revenue grows 59% to $122.7 million; Full-year 2018 revenue grows 79% to $417.9 million Fourth-quarter total visits up 86% to 861,000; 2018 total visits up 80% to 2.6 million Issues Initial 2019 Guidance [...]

NewLink Genetics Reports Fourth Quarter, Year-End 2018 Financial Results and Provides Update for Clinical Programs

27/02/2019 - 22:01

Management to Host Conference Call Today at 4:30 p.m. ET AMES, Iowa, Feb. 27, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the fourth quarter and [...]

aTyr Pharma Presents Compelling Preclinical Data Highlighting Potential of ATYR1923 to Regulate Myeloid Cell Biology During Lung Inflammation

27/02/2019 - 22:00

Poster presentation at the Keystone Symposia 2019 Conference: Myeloid Cells (B7) SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and [...]

GENFIT: PUBLICATION OF THE 2018 REGISTRATION DOCUMENT

27/02/2019 - 21:14

GENFIT: PUBLICATION OF THE 2018 REGISTRATION DOCUMENT Lille (France), Cambridge (Massachusetts, United States), February 27, 2019 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a late-stage biopharmaceutical company [...]

GENFIT : MISE À DISPOSITION DU DOCUMENT DE RÉFÉRENCE 2018

27/02/2019 - 21:14

GENFIT : MISE À DISPOSITION DU DOCUMENT DE RÉFÉRENCE 2018 Lille (France), Cambridge (Massachusetts, États-Unis), le 27 février 2019 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), Société biopharmaceutique de phase [...]

GENFIT : FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING IN THE UNITED STATES

27/02/2019 - 20:56

FOR IMMEDIATE RELEASE GENFIT FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING IN THE UNITED STATES Lille (France), Cambridge (Massachusetts, United States), February 27, 2019 GENFIT (Euronext: GNFT - [...]

GENFIT : ANNONCE LE DÉPÔT D'UN DOCUMENT D'ENREGISTREMENT EN VUE DE SON INTRODUCTION EN BOURSE ENVISAGÉE AUX ÉTATS-UNIS

27/02/2019 - 20:56

GENFIT ANNONCE LE DÉPÔT D'UN DOCUMENT D'ENREGISTREMENT EN VUE DE SON INTRODUCTION EN BOURSE ENVISAGÉE AUX ÉTATS-UNIS Lille (France), Cambridge (Massachusetts, États-Unis), le 27 février 2019 - GENFIT SA (Euronext : GNFT [...]

Aura Health Announces Closing of $1.9 Million on the First Tranche of Subscription Receipt Financing

27/02/2019 - 19:42

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Feb. 27, 2019 ( [...]

Teligent, Inc. to Present at The 8th Annual SVB Leerink Global Healthcare Conference Friday March 1, 2019

27/02/2019 - 19:08

BUENA, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at The 8 th Annual SVB Leerink Global Healthcare Conference [...]

Veloxis Pharmaceuticals Releases Annual Report for 2018

27/02/2019 - 19:02

Company Release no. 02/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 27 February 2019 Veloxis Pharmaceuticals Releases Annual Report for 2018 Veloxis Pharmaceuticals A/S (OMX: VELO) today releases its Annual [...]

RAMSAY GENERALE DE SANTE : Mise à disposition du rapport financier semestriel à fin décembre 2018

27/02/2019 - 18:05

Rapport financier semestriel au 31 décembre 2018 Ce document est disponible sur le site internet de RAMSAY GENERALE DE SANTE : http://www.ramsaygds.com A propos de Ramsay Générale de Santé : Après son OPA réussie sur le [...]